首页> 外文期刊>Journal of proteome research >Launching the C-HPP neXt-CP50 Pilot Project for Functional Characterization of Identified Proteins with No Known Function
【24h】

Launching the C-HPP neXt-CP50 Pilot Project for Functional Characterization of Identified Proteins with No Known Function

机译:启动C-HPP Next-CP50试点项目,用于识别的蛋白质的功能表征,没有已知功能

获取原文
获取原文并翻译 | 示例

摘要

An important goal of the Human Proteome Organization (HUPO) Chromosome-centric Human Proteome Project (C-HPP) is to correctly define the number of canonical proteins encoded by their cognate open reading frames on each chromosome in the human genome. When identified with high confidence of protein evidence (PE), such proteins are termed PE1 proteins in the online database resource, neXtProt. However, proteins that have not been identified unequivocally at the protein level but that have other evidence suggestive of their existence (PE2-4) are termed missing proteins (MPs). The number of MPs has been reduced from 5511 in 2012 to 2186 in 2018 (neXtProt 2018-01-17 release). Although the annotation of the human proteome has made significant progress, the "parts list" alone does not inform function. Indeed, 1937 proteins representing similar to 10% of the human proteome have no function either annotated from experimental characterization or predicted by homology to other proteins. Specifically, these 1937 "dark proteins" of the so-called dark proteome are composed of 1260 functionally uncharacterized but identified PE1 proteins, designated as uPE1, plus 677 MPs from categories PE2-PE4, which also have no known or predicted function and are termed uMPs. At the HUPO-2017 Annual Meeting, the C-HPP officially adopted the uPE1 pilot initiative, with 14 participating international teams later committing to demonstrate the feasibility of the functional characterization of large numbers of dark proteins (CP), starting first with SO uPE1 proteins, in a stepwise chromosome-centric organizational manner. The second aim of the feasibility phase to characterize protein (CP) functions of 50 uPE1 proteins, termed the neXt-CP50 initiative, is to utilize a variety of approaches and workflows according to individual team expertise, interest, and resources so as to enable the C-HPP to recommend experimentally proven workflows to the proteome community within 3 years. The results from this
机译:人类蛋白质组织(HUPO)以染色体为中心的人类蛋白质组项目(C-HPP)的重要目标是正确地定义通过其对人类基因组中每种染色体上的同源开放阅读框架编码的规范蛋白的数量。当鉴定蛋白质证据的高置信度(PE)时,这种蛋白质被称为在线数据库资源中的PE1蛋白,NextProt。然而,尚未在蛋白质水平上不确定鉴定的蛋白质,但具有其存在的其他证据(PE2-4)被称为缺失的蛋白质(MPS)。 2012年的5511年,MPS的数量已减少到2018年的2186(NextProt 2018-01-17发行版)。虽然人类蛋白质组的注释取得了重大进展,但单独的“零件清单”并未通知功能。实际上,代表类似于10%的人蛋白质组的1937蛋白没有功能与实验表征注释或通过同源性预测到其他蛋白质。具体地,所谓的暗蛋白质组的这1937个“暗蛋白”由1260个功能上不具巧但鉴定的PE1蛋白组成,被称为UPE1,以及来自类别PE2-PE4的677个MPS,其也没有已知或预测的功能并被称为umps。在Hupo-2017年度会议上,C-HPP正式通过了UPE1试点倡议,其中14名参加国际团队稍后致力于展示大量暗蛋白(CP)功能表征的可行性,首先用SO UPE1蛋白开始,以逐步染色体为中心的组织方式。蛋白质(CP)的可行性阶段的第二个目的是50 upe1蛋白的函数,称为下一个CP50倡议,是根据各个团队专业知识,兴趣和资源使用各种方法和工作流程,以便启用C-HPP建议在3年内向蛋白质组社区进行实验证明工作流程。这是由此

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号